B. Quintana Ab (IgM), Screen

Negative
A negative result for the B. Quintana Ab (IgM) test generally suggests that there are no detectable IgM antibodies against Bartonella quintana in the patient's blood, indicating a lack of recent infection with this bacterium. However, this does not definitively rule out an infection, as it could either be too early for IgM antibodies to have developed, or the infection may be in a later stage where IgM antibodies are no longer present. Instead, IgG antibodies might be found in chronic or past infections. The sensitivity and specificity of the test also play a role, as low antibody levels might not be detected. Therefore, it's important to consider this result within the broader context of the patient's clinical symptoms, history, and other diagnostic tests. Further investigation may be needed for a conclusive diagnosis.
Positive
A positive result for B. Quintana Ab (IgM) signifies the presence of IgM antibodies against Bartonella quintana in the patient's blood. This finding typically indicates a recent or current active infection with the bacterium. IgM antibodies are the first to be produced by the immune system in response to an infection, and their presence suggests that the infection is in its early stages. Bartonella quintana is known to cause conditions such as trench fever, bacillary angiomatosis, and endocarditis, particularly in immunocompromised individuals. A positive IgM test is especially valuable in diagnosing these infections early on, often before the appearance of IgG antibodies. However, it's important to interpret a positive IgM result in conjunction with the patient's clinical symptoms, history, and other diagnostic findings, as IgM antibodies can sometimes cross-react with antigens from other pathogens, leading to potential false positives. Additionally, the patient's exposure history and risk factors for Bartonella quintana infection should be considered to accurately assess the significance of the test result.

Bartonella quintana antibody (IgM) testing is an important diagnostic tool used to detect acute infections caused by Bartonella quintana, a bacterium associated with several serious conditions, including trench fever, bacillary angiomatosis, and endocarditis. The presence of IgM antibodies against B. quintana in a patient's blood is a key indicator of recent or ongoing infection. IgM is the first class of antibodies the body produces in response to an infection. These antibodies typically become detectable within a short period after initial exposure to the pathogen, often within days to a few weeks. Therefore, a positive IgM test for B. quintana is particularly valuable in diagnosing early-stage infections, especially in patients presenting with symptoms like fever, body aches, or more severe manifestations related to the bacterium's effects on the vascular system or heart valves. However, IgM antibodies have a relatively short lifespan in the blood, and their levels can decrease to undetectable levels as the infection progresses or after it has been resolved. Consequently, a negative IgM test does not necessarily rule out a B. quintana infection, particularly in cases where the exposure occurred some time ago or in chronic infections. The test's sensitivity and specificity, as well as the timing of the test in relation to symptom onset, are crucial factors in interpreting results.

B. Quintana Ab (IgM), Screen
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond B. Quintana Ab (IgM), Screen — 10,000+ markers explained
One B. Quintana Ab (IgM), Screen result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro